+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Contrast Enhanced Digital Mammography Market Size By Technique, By Applications, By End User, By Geographic Scope And Forecast

  • Report

  • 90 Pages
  • April 2021
  • Region: Global
  • Verified Market Research
  • ID: 5440657
Contrast Enhanced Digital Mammography (CEDM) Market was valued at USD 303.46 Million in 2020 and is projected to reach USD 637.54 Million by 2028, growing at a CAGR of 9.92% from 2021 to 2028.



The Contrast Enhanced Digital Mammography (CEDM) Market report provides a holistic evaluation of the market for the forecast period. The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics, involves the drivers, restraints, opportunities and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Contrast Enhanced Digital Mammography (CEDM) Market study provides an outlook on the development of market in terms of revenue throughout the prognosis period.

Global Contrast Enhanced Digital Mammography (CEDM) Market Overview


Contrast Enhanced Digital Mammography (CEDM) is a highly popular and most commonly used technique across the globe owing to the rising prevalence of breast cancer. Age, obesity, harmful alcohol use, family history of breast cancer, history of radiation exposure, reproductive history (age at first menstrual cycle and age at first pregnancy), tobacco use, and postmenopausal hormone therapy are all factors that raise the risk of breast cancer.

This report provides an all-inclusive environment of the analysis for the Contrast Enhanced Digital Mammography (CEDM) Market. The market estimates provided in the report are the result of in-depth secondary research, primary interviews and in-house expert reviews. These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics affecting the Contrast Enhanced Digital Mammography (CEDM) Market growth.

Along with the market overview, which comprises of the market dynamics the chapter includes a Porter’s Five Forces analysis which explains the five forces: namely buyers bargaining power, suppliers bargaining power, threat of new entrants, threat of substitutes, and degree of competition in the Contrast Enhanced Digital Mammography (CEDM) Market. It explains the various participants, such as system integrators, intermediaries and end-users within the ecosystem of the market. The report also focuses on the competitive landscape of the Contrast Enhanced Digital Mammography (CEDM) Market.

Global Contrast Enhanced Digital Mammography (CEDM) Market: Segmentation Analysis


The Global Contrast Enhanced Digital Mammography (CEDM) Market is segmented on the basis of Technique, Application, End User, and Geography.

Key Players


The “Global Contrast Enhanced Digital Mammography (CEDM) Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as GE Healthcare, Siemens Healthineers (Siemens AG), Allengers Medical Systems Limited, Planmed Oy, Hologic, Inc., and Others.
Frequently Asked Questions about the Global Contrast Enhanced Digital Mammography Market

What is the estimated value of the Global Contrast Enhanced Digital Mammography Market?

The Global Contrast Enhanced Digital Mammography Market was estimated to be valued at $303.46 Million in 2020.

What is the growth rate of the Global Contrast Enhanced Digital Mammography Market?

The growth rate of the Global Contrast Enhanced Digital Mammography Market is 9.7%, with an estimated value of $637.54 Million by 2028.

What is the forecasted size of the Global Contrast Enhanced Digital Mammography Market?

The Global Contrast Enhanced Digital Mammography Market is estimated to be worth $637.54 Million by 2028.

Who are the key companies in the Global Contrast Enhanced Digital Mammography Market?

Key companies in the Global Contrast Enhanced Digital Mammography Market include GE Healthcare, Siemens Healthineers, Allengers Medical Systems Limited, Planmed Oy, Hologic Inc., Koninklijke Philips N.V., BMI Biomedical International S.R.L. and Carestream Health.

Table of Contents

1 Introduction
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations
2 Research Methodology
2.1 Data Mining
2.2 Secondary Research
2.3 Primary Research
2.4 Subject Matter Expert Advice
2.5 Quality Check
2.6 Final Review
2.7 Data Triangulation
2.8 Bottom-Up Approach
2.9 Top Down Approach
2.10 Research Flow
3 Executive Summary
3.1 Market Overview
3.2 Global Contrast Enhanced Digital Mammography (Cedm) Market Geographical Analysis (Cagr %)
3.3 Global Contrast Enhanced Digital Mammography (Cedm) Market, by Technique (Usd Million)
3.4 Global Contrast Enhanced Digital Mammography (Cedm) Market, by Application (Usd Million)
3.5 Global Contrast Enhanced Digital Mammography (Cedm) Market, by End-user (Usd Million)
3.6 Future Market Opportunities
3.7 Global Market Split
4 Market Outlook
4.1 Global Contrast Enhanced Digital Mammography (Cedm) Market Outlook
4.2 Market Drivers
4.2.1 Rising Prevalence of the Breast Cancer Across the Globe
4.2.2 Advantages of Cedm Over the Breast Mri and Standard Mammography in Detecting Breast Tumors
4.3 Market Restraint
4.3.1 Limitations Related to Cost and Specificity
4.4 Market Opportunities
4.4.1 Advent of New Technology to Drive Market
4.5 Impact of Covid-19 on Global Contrast Enhanced Digital Mammography (Cedm) Market
5 Market, by Technique
5.1 Overview
5.2 Temporal Subtraction
5.3 Dual Energy Cedm
6 Market, by Application
6.1 Overview
6.2 Screening
6.3 Diagnosis
7 Market, by End-User
7.1 Overview
7.2 Hospital
7.3 Diagnostic Centres
7.4 Specialty Clinics
7.5 Others
8 Market, by Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia-Pacific
8.5 Rest of World
8.5.1 Middle East and Africa
8.5.2 Latin America
9 Competitive Landscape
9.1 Overview
9.2 Competitive Scenario
9.3 Company Market Ranking Analysis
10 Company Profiles
10.1 Siemens Healthcare GmbH
10.1.1 Company Overview
10.1.2 Company Insights
10.1.3 Segment Breakdown
10.1.4 Product Benchmarking
10.1.5 Key Development
10.1.6 SWOT Analysis
10.2 GE Healthcare
10.2.1 Company Overview
10.2.2 Company Insights
10.2.3 Segment Breakdown
10.2.4 Product Benchmarking
10.2.5 Key Development
10.2.6 SWOT Analysis
10.3 Hologic Inc.
10.3.1 Company Overview
10.3.2 Company Insights
10.3.3 Segment Breakdown
10.3.4 Product Benchmarking
10.3.5 Key Development
10.3.6 SWOT Analysis
10.4 Allengers
10.4.1 Company Overview
10.4.2 Company Insights
10.4.3 Product Benchmarking
10.4.4 Key Development
10.5 Planmed Oy
10.5.1 Company Overview
10.5.2 Company Insights
10.5.3 Product Benchmarking
10.5.4 Key Development
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Company Insights
10.6.3 Segment Breakdown
10.6.4 Product Benchmarking
10.6.5 Key Development
10.7 Bmi Biomedical International S.R.L.
10.7.1 Company Overview
10.7.2 Company Insights
10.7.3 Product Benchmarking
10.8 Carestream Health
10.8.1 Company Overview
10.8.2 Company Insights
10.8.3 Product Benchmarking

Companies Mentioned

A selection of companies mentioned in this report includes:

  • GE Healthcare
  • Siemens Healthineers
  • Allengers Medical Systems Limited
  • Planmed Oy
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • BMI Biomedical International S.R.L.
  • Carestream Health

Methodology

Loading
LOADING...